The statistical analysis confirmed the significance of these findings, with a highly significant p for TPD + azeliragon (in the presence of S100-A11r) vs.
← all excerpts
Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer.
1
—
—